Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators.

[1]  W. P. Dixon,et al.  BMPD statistical software manual , 1988 .

[2]  E. Topol,et al.  A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. , 1987, The New England journal of medicine.

[3]  H. White,et al.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. , 1987, The New England journal of medicine.

[4]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[5]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[6]  J. Knoke,et al.  Acute myocardial infarction: prognosis after recovery. , 1976, Annals of internal medicine.

[7]  A. Moss,et al.  The Early Posthospital Phase of Myocardial Infarction: Prognostic Stratification , 1976, Circulation.

[8]  S. Kullander,et al.  HUMAN PLACENTAL LACTOGEN IN SCREENING FOR MULTIPLE PREGNANCIES , 1975, The Lancet.

[9]  P. Brandt,et al.  A new coronary prognostic index. , 1969, American heart journal.

[10]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[11]  A. Peel,et al.  A CORONARY PROGNOSTIC INDEX FOR GRADING THE SEVERITY OF INFARCTION , 1962, British heart journal.